Jeffrey L. Ives - Net Worth and Insider Trading
Jeffrey L. Ives Net Worth
The estimated net worth of Jeffrey L. Ives is at least $4,350 dollars as of 2024-11-05. Jeffrey L. Ives is the Director of Cara Therapeutics Inc and owns about 15,476 shares of Cara Therapeutics Inc (CARA) stock worth over $4,350. Jeffrey L. Ives is also the Director of Acumen Pharmaceuticals Inc and owns about 0 shares of Acumen Pharmaceuticals Inc (ABOS) stock worth over $0. Details can be seen in Jeffrey L. Ives's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jeffrey L. Ives has not made any transactions after 2023-08-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jeffrey L. Ives
Jeffrey L. Ives Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jeffrey L. Ives owns 2 companies in total, including Cara Therapeutics Inc (CARA) , and Acumen Pharmaceuticals Inc (ABOS) .
Click here to see the complete history of Jeffrey L. Ives’s form 4 insider trades.
Insider Ownership Summary of Jeffrey L. Ives
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CARA | Cara Therapeutics Inc | 2022-07-15 | director |
| ABOS | Acumen Pharmaceuticals Inc | 2023-08-17 | director |
Jeffrey L. Ives Latest Holdings Summary
Jeffrey L. Ives currently owns a total of 2 stocks. Among these stocks, Jeffrey L. Ives owns 15,476 shares of Cara Therapeutics Inc (CARA) as of July 15, 2022, with a value of $4,350 and a weighting of 100%. Jeffrey L. Ives also owns 0 shares of Acumen Pharmaceuticals Inc (ABOS) as of August 17, 2023, with a value of $0 and a weighting of 0%.
Latest Holdings of Jeffrey L. Ives
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CARA | Cara Therapeutics Inc | 2022-07-15 | 15,476 | 0.28 | 4,350 |
| ABOS | Acumen Pharmaceuticals Inc | 2023-08-17 | 0 | 2.95 | 0 |
Holding Weightings of Jeffrey L. Ives
Jeffrey L. Ives Form 4 Trading Tracker
According to the SEC Form 4 filings, Jeffrey L. Ives has made a total of 11 transactions in Cara Therapeutics Inc (CARA) over the past 5 years, including 0 buys and 11 sells. The most-recent trade in Cara Therapeutics Inc is the sale of 3,600 shares on July 15, 2022, which brought Jeffrey L. Ives around $32,580.
According to the SEC Form 4 filings, Jeffrey L. Ives has made a total of 1 transactions in Acumen Pharmaceuticals Inc (ABOS) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Acumen Pharmaceuticals Inc is the sale of 41,949 shares on August 17, 2023, which brought Jeffrey L. Ives around $272,249.
Insider Trading History of Jeffrey L. Ives
- 1
Jeffrey L. Ives Trading Performance
Jeffrey L. Ives Ownership Network
Ownership Network List of Jeffrey L. Ives
Ownership Network Relation of Jeffrey L. Ives
Jeffrey L. Ives Owned Company Details
What does Cara Therapeutics Inc do?
Who are the key executives at Cara Therapeutics Inc?
Jeffrey L. Ives is the director of Cara Therapeutics Inc. Other key executives at Cara Therapeutics Inc include Chief Medical Officer Joana Goncalves , Sec'y; Chief Compliance & G.C. Scott Terrillion , and VP-Research & Development Menzaghi Frederique Ph.d. .
Cara Therapeutics Inc (CARA) Insider Trades Summary
Over the past 18 months, Jeffrey L. Ives made no insider transaction in Cara Therapeutics Inc (CARA). Other recent insider transactions involving Cara Therapeutics Inc (CARA) include a net sale of 56,744 shares made by Christopher Posner , a net sale of 5,476 shares made by Joana Goncalves , and a net sale of 5,236 shares made by Scott Terrillion .
In summary, during the past 3 months, insiders sold 0 shares of Cara Therapeutics Inc (CARA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 70,449 shares of Cara Therapeutics Inc (CARA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 70,449 shares.
Cara Therapeutics Inc (CARA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cara Therapeutics Inc Insider Transactions
Jeffrey L. Ives Mailing Address
Above is the net worth, insider trading, and ownership report for Jeffrey L. Ives. You might contact Jeffrey L. Ives via mailing address: C/o Cara Therapeutics, Inc., 1 Parrott Drive, Shelton Ct 06484.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
